| 房颤抗凝治疗问题的探讨 |
| |
| 引用本文： | 袁大军. 房颤抗凝治疗问题的探讨[J]. 医学与哲学(人文社会医学版), 2006, 27(6): 38-39 |
| |
| 作者姓名： | 袁大军 |
| |
| 作者单位： | 大连医科大学附属第二医院 辽宁大连116027 |
| |
| 摘 要： | 房颤易出现栓塞的并发症,而华法林可以明显减少血栓栓塞事件。阵发性房颤同样有血栓栓塞的危险,也应积极抗凝。具体的抗凝强度(PTINR目标值)在各个实验中差别很大,因为人种的关系,我们应该借鉴日本的研究结果。另外,许多因素会影响华法林的抗凝效果,要注意监测。
|
| 关 键 词： | 房颤 华法林 抗凝 |
| 文章编号： | 1002-0772（2006）06-0038-02 |
| 收稿时间： | 2006-04-15 |
| 修稿时间： | 2006-04-152006-06-10 |
Discussion on Anticoagulation in Patients with Atrial Fibrillation |
| |
| YUAN Da-jun. Discussion on Anticoagulation in Patients with Atrial Fibrillation[J]. Medicine & Philosophy:Humanistic & Social Medicine Edition, 2006, 27(6): 38-39 |
| |
| Authors: | YUAN Da-jun |
| |
| Affiliation: | Department of Cardiology, the Second Affiliated Hospital of Dalian Medical University, Dalian 116027, China |
| |
| Abstract: | Embolism is likely to occur in patients with atrial fibrillation, warfarin treatment can obviously decrease thromboembolic episodes. Patients with intermittent atrial fibrillation also have the risk of thromboembolism and should be treated with .anticoagulation. The different in intensity of warfarin treatment was large among the trials, we should refer to the results of the study in Japanese. because of the race. In addition, because many factors can influence the effective of anticoagulation, anticoagulation treatment should be used with caution and carefully monitored. |
| |
| Keywords: | atrial fibrillation warfarin anticoagulation |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
